Safety and efficacy of biologic immunosuppressive treatment in juvenile idiopathic arthritis associated with inborn errors of immunity

Safety and efficacy of biologic immunosuppressive treatment in juvenile idiopathic arthritis associated with inborn errors of immunity

ObjectivesThis study aims to describe clinical features, therapeutic outcomes, and safety profiles in patients affected by juvenile idiopathic arthritis (JIA) and inborn errors of immunity (IEI) treated with biological Disease-modifying antirheumatic drugs (DMARDs).MethodsWe enrolled three patients...

Full description

Bibliographic Details
Main Authors: V. Accardo, I. Pagnini, I. Maccora, E. Marrani, M. V. Mastrolia, G. Simonini
Format: Article
Language:English
Published: Frontiers Media S.A. 2024-02-01
Series:Frontiers in Pediatrics
Subjects:
arthritis
juvenile
inborn errors of immunity
DiGeorge syndrome
Bruton-type agammaglobulinemia
adalimumab
Online Access:https://www.frontiersin.org/articles/10.3389/fped.2024.1353825/full

Internet

https://www.frontiersin.org/articles/10.3389/fped.2024.1353825/full

Similar Items